We further examined MBNL1 expression across two major primary patient datasets evaluating both AML and ALL, and consistently found high MBNL1 expression in MLL-rearranged patient samples23–28 (Supplementary Figs. 1A–C). Here, KMT2A is linked to acute myeloid leukemia.